These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 14118696)
1. CANADA'S NEW DRUG REGULATIONS. WARNER P; GLASSCO A; KROEKER J Can Med Assoc J; 1964 Feb; 90(8):540-1. PubMed ID: 14118696 [No Abstract] [Full Text] [Related]
2. Canada's food and drug regulations. CURRAN RE Food Drug Cosmet Law Q; 1949 Sep; 4(3):391-411. PubMed ID: 18139337 [No Abstract] [Full Text] [Related]
3. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States. Cunningham JK; Liu LM; Callaghan R Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353 [TBL] [Abstract][Full Text] [Related]
4. Canada's approach to biosimilars questioned. Webster PC CMAJ; 2015 Nov; 187(16):1199. PubMed ID: 26464133 [No Abstract] [Full Text] [Related]
5. Health Canada's Progressive Licensing Framework. Yeates N; Lee DK; Maher M CMAJ; 2007 Jun; 176(13):1845-7. PubMed ID: 17576983 [No Abstract] [Full Text] [Related]
6. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions. Callaghan RC; Cunningham JK; Victor JC; Liu LM Drug Alcohol Depend; 2009 Dec; 105(3):185-93. PubMed ID: 19699042 [TBL] [Abstract][Full Text] [Related]
7. Canada's contribution to global research in cardiovascular diseases. Nguyen HV; de Oliveira C; Wijeysundera HC; Wong WW; Woo G; Grootendorst P; Liu PP; Krahn MD Can J Cardiol; 2013 Jun; 29(6):742-6. PubMed ID: 23219608 [TBL] [Abstract][Full Text] [Related]
8. Requests approaching 50,000 annually for emergency drug release program. Robinson A CMAJ; 1995 Sep; 153(5):665-6. PubMed ID: 7641166 [TBL] [Abstract][Full Text] [Related]
9. Health Canada's use of its priority review process for new drugs: a cohort study. Lexchin J BMJ Open; 2015 May; 5(5):e006816. PubMed ID: 25967989 [TBL] [Abstract][Full Text] [Related]
11. A critical public-health ethics analysis of Canada's international response to HIV. Nixon SA; Benatar SR Glob Public Health; 2011; 6(7):777-93. PubMed ID: 21390963 [TBL] [Abstract][Full Text] [Related]
12. Governance of natural health products regulation: an iterative process. Walji R; Wiktorowicz M Health Policy; 2013 Jun; 111(1):86-94. PubMed ID: 23523344 [TBL] [Abstract][Full Text] [Related]
13. Herbal products begin to attract the attention of brand-name drug companies. Cottrell K CMAJ; 1996 Jul; 155(2):216-9. PubMed ID: 8800080 [TBL] [Abstract][Full Text] [Related]
14. Proposed drug manufacturing regulations in Canada. KALBFLEISCH GL Bull Parenter Drug Assoc; 1962; 16():16-21. PubMed ID: 13961895 [No Abstract] [Full Text] [Related]
15. Canada's Patented Medicines (Notice of Compliance) Proceedings and Intellectual Property. Bian H; McCourt C Cold Spring Harb Perspect Med; 2015 Jan; 5(6):. PubMed ID: 25573772 [TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS and injection drug use: a national (and rational) plan. Oscapella E Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):19-22. PubMed ID: 11365282 [TBL] [Abstract][Full Text] [Related]
17. Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles? Hollis A Expert Opin Ther Pat; 2018 Jan; 28(1):1-3. PubMed ID: 28974123 [No Abstract] [Full Text] [Related]
18. Canada's 2003 renewed drug strategy--an evidence-based review. DeBeck K; Wood E; Montaner J; Kerr T HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):1, 5-12. PubMed ID: 17373058 [TBL] [Abstract][Full Text] [Related]
19. Awareness and Knowledge of Recommendations from Canada's Food Guide. Vanderlee L; McCrory C; Hammond D Can J Diet Pract Res; 2015 Sep; 76(3):146-9. PubMed ID: 26280795 [TBL] [Abstract][Full Text] [Related]